Vivek Kumar Dwivedi

Summary

Publications

  1. pmc Protective role of ceftriaxone plus sulbactam with VRP1034 on oxidative stress, hematological and enzymatic parameters in cadmium toxicity induced rat model
    Vivek Kumar Dwivedi
    Preclinical Divison, Venus Medicine Research Centre, Baddi, H P 173205 India
    Interdiscip Toxicol 5:192-200. 2012
  2. ncbi Fixed-dose combination of cefepime plus amikacin (potentox) inhibits pneumonia infection
    V K Dwivedi
    Intellectual Scientific Division, Venus Medicine Research Centre, Bhatoli Kalan, Baddi, India
    Exp Lung Res 35:621-9. 2009
  3. ncbi Fixed dose combination of cefepime plus amikacin prevent oxidative stress in liver of Mus musculus mice
    Manu Chaudhary
    Intellectual Scientific Division, Venus Medicine Research Centre, Hill Top Industrial Estate, Bhatoli Kalan, Baddi, H P 173205 India
    Curr Clin Pharmacol 3:211-4. 2008
  4. ncbi Ceftriaxone-vancomycin drug toxicity reduction by VRP 1020 in Mus musculus mice
    Arvind Soni
    Intellectual Scientific Division, Venus Medicine Research Center, Hill Top Industrial Estate, Bhatoli Kalan, Baddi, H P 173205 India
    Curr Clin Pharmacol 4:95-101. 2009
  5. ncbi Sub-acute toxicity study of a new aminoglycoside etimicin sulphate in swiss albino mice
    Anurag Payasi
    Office of Research Support, Venus Medicine Research Centre, Hill Top Industrial Estate, Bhatoli Kalan, Baddi, HP, India
    J Toxicol Sci 35:479-84. 2010
  6. ncbi Pharmacokinetic study of sulbactomax
    Anurag Payasi
    Office of Research Support, Venus Medicine Research Centre, Hill Top Industrial Estate, Bhatoli Kalan, Baddi, HP, India
    J Toxicol Sci 35:459-64. 2010

Collaborators

  • Manu Chaudhary
  • Anurag Payasi
  • Arvind Soni
  • Ankush Gupta
  • Anuj Bhatnagar

Detail Information

Publications6

  1. pmc Protective role of ceftriaxone plus sulbactam with VRP1034 on oxidative stress, hematological and enzymatic parameters in cadmium toxicity induced rat model
    Vivek Kumar Dwivedi
    Preclinical Divison, Venus Medicine Research Centre, Baddi, H P 173205 India
    Interdiscip Toxicol 5:192-200. 2012
    ....
  2. ncbi Fixed-dose combination of cefepime plus amikacin (potentox) inhibits pneumonia infection
    V K Dwivedi
    Intellectual Scientific Division, Venus Medicine Research Centre, Bhatoli Kalan, Baddi, India
    Exp Lung Res 35:621-9. 2009
    ..These studies concluded that fixed-dose combination of potentox improved oxidant and antioxidant levels in pneumonia infection...
  3. ncbi Fixed dose combination of cefepime plus amikacin prevent oxidative stress in liver of Mus musculus mice
    Manu Chaudhary
    Intellectual Scientific Division, Venus Medicine Research Centre, Hill Top Industrial Estate, Bhatoli Kalan, Baddi, H P 173205 India
    Curr Clin Pharmacol 3:211-4. 2008
    ..These findings suggest that the fixed dose combination therapy of cefepime + amikacin (Potentox) show significant free radical scavenging property which may contribute to decrease in aminoglycoside induced liver injury...
  4. ncbi Ceftriaxone-vancomycin drug toxicity reduction by VRP 1020 in Mus musculus mice
    Arvind Soni
    Intellectual Scientific Division, Venus Medicine Research Center, Hill Top Industrial Estate, Bhatoli Kalan, Baddi, H P 173205 India
    Curr Clin Pharmacol 4:95-101. 2009
    ....
  5. ncbi Sub-acute toxicity study of a new aminoglycoside etimicin sulphate in swiss albino mice
    Anurag Payasi
    Office of Research Support, Venus Medicine Research Centre, Hill Top Industrial Estate, Bhatoli Kalan, Baddi, HP, India
    J Toxicol Sci 35:479-84. 2010
    ..The result of this study has suggested there was no obvious toxicity observed with the treatment of etimicin sulphate. It was found to be a safe alternative for various severe infections...
  6. ncbi Pharmacokinetic study of sulbactomax
    Anurag Payasi
    Office of Research Support, Venus Medicine Research Centre, Hill Top Industrial Estate, Bhatoli Kalan, Baddi, HP, India
    J Toxicol Sci 35:459-64. 2010
    ....